CRC Research Update — August 27, 2026
Today's colorectal cancer research highlights
stage-i-ii
A collection of 45 issues
Circulating Tumor DNA Shows Promise for Guiding Adjuvant Therapy After Curative Surgery
Skip to content
The CRC Digest
◇ RESEARCH
Circulating Tumor DNA Shows Promise for Guiding Adjuvant Therapy After Curative Surgery
A review examines how circulating tumor DNA (ctDNA) offers a dynamic readout of molecular residual disease in the postoperative period, potentially guiding adjuvant treatment decision-making in stage II (15-20% recurrence) and
CRC Research Update — August 26, 2026
Today's colorectal cancer research highlights
CRC Research Update — August 24, 2026
Today's colorectal cancer research highlights
CRC Research Update — August 23, 2026
Today's colorectal cancer research highlights
CRC Research Update — August 22, 2026
Today's colorectal cancer research highlights
HER2 amplification studied in resectable CRC
Skip to content
The CRC Digest
HER2 amplification studied in resectable CRC
A study of 3,607 patients with resectable colorectal cancer investigated the prognostic impact of WES-defined ERBB2 amplification and its association with adjuvant chemotherapy efficacy and circulating tumor DNA. (Int J Clin Oncol)
This content is informational only
CRC Research Update — August 13, 2026
Today's colorectal cancer research highlights
Dementia Linked to Lower Surgery Rates and Survival in Stage I-III Colorectal Cancer
Skip to content
The CRC Digest
♥ LIVING WITH CRC
Dementia Linked to Lower Surgery Rates and Survival in Stage I-III Colorectal Cancer
Analysis of the Indiana Cancer Registry found that patients with dementia and stage I-III colorectal cancer have increased mortality and receive less invasive evaluations and surgery, with surgery
CRC Research Update — August 07, 2026
Today's colorectal cancer research highlights